We are international
Donate
• IMF TV TEXT SIZE   
Ask Dr. Durie    back

Can Zometa® be used alone to treat myeloma with bone disease?
05.06.13

Be the first to comment

 related articles
What does the deleti...
Should all myeloma p...
Can weakness, dizzin...
Should you have a st...
How do I find a myel...
What kinds of scan c...
How common is toxopl...
What are the practic...
Whats the latest upd...
Is the combination o...
Are veterans with my...
How does myeloma aff...
What is IVIG?
Is chiropractic care...
Does pomalidomide wo...
When will the first ...
If stringent complet...
What are myeloma tre...
Does the type of mye...
Dr. Durie, what is y...
What is the recommen...
What is the typical ...
What are some treatm...
What does ‘dysplasia...
Should gadolinium be...
What is the M protei...
If bone density is l...
What is the 17p dele...
#AskDrDurie: What’s ...
#AskDrDurie: What do...
#AskDrDurie: Why was...
#AskDrDurie: What's...
#AskDrDurie: Can Cyt...
#AskDrDurie: What ha...
#AskDrDurie: Can the...
#AskDrDurie: Is it p...
#AskDrDurie: What is...
#AskDrDurie: How doe...
#AskDrDurie: What is...
#AskDrDurie: Is auto...
#AskDrDurie: Has the...
#AskDrDurie: If Poma...
#AskDrDurie: Is ther...
#AskDrDurie: How can...
#AskDrDurie: Is it o...
#AskDrDurie: What ar...
#AskDrDurie: Should ...
#AskDrDurie: How can...
#AskDrDurie: Can a l...
#AskDrDurie: Does ag...
#AskDrDurie: Is MRI ...
#AskDrDurie: Are the...
#AskDrDurie: Are cl...
#AskDrDurie: How doe...
#AskDrDurie: Are PET...
#AskDrDurie: In ligh...
#AskDrDurie: Should ...
#AskDrDurie: If Myel...
#AskDrDurie: My Mai...
#AskDrDurie: My Doc...
#AskDrDurie: Is Stop...
#AskDrDurie: Does "...
#AskDrDurie: If Mye...
#AskDrDurie: I Need ...
#AskDrDurie: Is Part...
#AskDrDurie: Can Mye...
#AskDrDurie: What Ab...
#AskDrDurie: What Is...
#AskDrDurie: What Is...
#AskDrDurie: Should ...
#AskDrDurie: How Can...
#AskDrDurie: Are The...
#AskDrDurie: Should ...
#AskDr.Durie: Is Che...
#AskDrDurie: What Di...
#AskDrDurie: What's ...
#AskDrDurie: Is MGUS...
#AskDrDurie: ASCT Fo...
#AskDrDurie: Can Zom...
#AskDrDurie: Are Cat...
#AskDrDurie: How Do ...
#AskDrDurie: Is Kidn...
#AskDrDurie: Which o...
#AskDrDurie: How clo...

What does the deletion of chromosome 17 mean?
Should all myeloma patients be screened for amyloidosis?
Can weakness, dizziness and other symptoms be caused by a Vitamin B12 deficiency?
Should you have a stem cell transplant even after a partial response to treatment?
How do I find a myeloma specialist in my area?
What kinds of scan can determine if bone pain indicates new myeloma disease?
How common is toxoplasmosis infection?
What are the practical details of FISH testing?
Whats the latest update on the Black Swan Research Initiative®?
Is the combination of Kyprolis, Cytoxan and dexamethasone available as a treatment?
Are veterans with myeloma a unique population?
How does myeloma affect the immune system?
What is IVIG?
Is chiropractic care an option for patients with myeloma?
Does pomalidomide work on a myeloma patient that has not had a response with other iMiDs?
When will the first monoclonal antibody be approved?
If stringent complete remission is achieved, is maintenance therapy still required?
What are myeloma treatment options for a patient with bipolar disorder?
Does the type of myeloma impact the choice of treatment?
Dr. Durie, what is your perspective on the discussion about the cost of cancer drugs?
What is the recommended use of Biaxin in patients with myeloma?
What is the typical speed of improvement in the Freelite and protein levels with myeloma treatment?
What are some treatment options for the t(4;14) abnormality?
What does ‘dysplasia’ mean within the bone marrow report?
Should gadolinium be used as part of MRI testing?
What is the M protein?
If bone density is low, does that mean myeloma is present?
What is the 17p deletion?
#AskDrDurie: What’s new with the Black Swan Research Initiative®?
#AskDrDurie: What does IMWG’s new diagnostic criteria mean for myeloma patients?
#AskDrDurie: Why wasn’t panobinostat approved?
#AskDrDurie: What's new at ASH 2014
#AskDrDurie: Can Cytoxan cause heart damage?
#AskDrDurie: What happens to stem cells once they are harvested?
#AskDrDurie: Can the Hevylite™ test be used to monitor IgA myeloma?
#AskDrDurie: Is it possible to have short remissions without high-risk features?
#AskDrDurie: What is remission?
#AskDrDurie: How does the IMF contribute to the myeloma community?
#AskDrDurie: What is Selinexor
#AskDrDurie: Is autologous stem cell transplant still recommended?
#AskDrDurie: Has there been any change in recommendations used to treat bone disease in myeloma?
#AskDrDurie: If Pomalyst does not produce a full response, what are my options?
#AskDrDurie: Is there a test available for measuring Minimal Residual Disease, what we call MRD?
#AskDrDurie: How can Revlimid’s diarrhea side effect be handled?
#AskDrDurie: Is it okay to take vitamin B12 on the same day as Velcade?
#AskDrDurie: What are the important aspects of different types of imaging, such as regular x-rays, MRI, CT, and PET?
#AskDrDurie: Should I have an ASCT if I've been through therapy and am in remission?
#AskDrDurie: How can myeloma suddenly go from standard to high risk?
#AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?
#AskDrDurie: Does age make a difference in selecting myeloma treatment?
#AskDrDurie: Is MRI testing important to see if treatment is necessary for smoldering myeloma?
#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?
#AskDrDurie: Are clinical trials part of the Black Swan Research Initiative(R), and if so, how can I participate?
#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?
#AskDrDurie: Are PET/CT scans useful for a patient with MGUS?
#AskDrDurie: In light of Tom Brokaw's recent myeloma diagnosis, is better early screening required?"
#AskDrDurie: Should Patients With Similar Types of Myeloma Form Separate Support Groups?
#AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?
#AskDrDurie: My Maintenance was Stopped Because the Side Effects were Too Bad. How Common is That?
#AskDrDurie: My Doctor Thinks the Myeloma Treatment is Damaging my Liver: Is That Correct?
#AskDrDurie: Is Stopping Pomalidomide After 1 Month Okay?
#AskDrDurie: Does "Big Data Analysis" Apply to Myeloma Patients?
#AskDrDurie: If Myeloma is CD 38 Positive, Shouldn't Anti-CD 38 Antibodies Work for All Patients?
#AskDrDurie: I Need to Have Surgery: Can I Do That?
#AskDrDurie: Is Partial Response Or Very Good Partial Response Good Enough?
#AskDrDurie: Can Myeloma Run In The Family?
#AskDrDurie: What About The Role Of Antibody Therapy In Myeloma?
#AskDrDurie: What Is "Off Label" Use?
#AskDrDurie: What Is Recommended for Smoldering Myeloma?
#AskDrDurie: Should I be in a Clinical Trial
#AskDrDurie: How Can Myeloma Patients Avoid Infection?
#AskDrDurie: Are There Special Precautions for Myeloma Patients in the Summer?
#AskDrDurie: Should I Be On Maintenance Therapy?
#AskDr.Durie: Is Chemobrain Real?
#AskDrDurie: What Diet Is Recommended For Myeloma Patients?
#AskDrDurie: What's New From ASCO/EHA/IMWG Summit?
#AskDrDurie: Is MGUS A Tumor, And What Is Being Done To Prevent It?
#AskDrDurie: ASCT For Younger Patients - Is Disease "Control" Sufficient?
#AskDrDurie: Can Zometa® be used alone to treat myeloma with bone disease?
#AskDrDurie: Are Cataracts a Side Effect of Treatment with Revlimid?
#AskDrDurie: How Do I Get Rid of Bone Pain?
#AskDrDurie: Is Kidney Transplant Possible for Myeloma Patients?
#AskDrDurie: Which of the new treatments are the most exciting?
#AskDrDurie: How close are we to a cure?


You might also be interested in:

What does the deletion of chromosome 17 mean?

In this week's video, Dr. Brian Durie discusses how the deletion of chromosome 17 mean to myeloma patients.

Bottom Line:

Chromosome 17 deletion could mean you need extra care and treatment.


Should all myeloma patients be screened for amyloidosis?

In this week's video Dr. Brian Durie answers Laura Mooney's question about amyloidosis and if myeloma patients should be screened for it. Laura is the leader of the Staten Island Support Group.

Bottom Line:

Keep amyloidosis testing on your doctor's check list.


Can weakness, dizziness and other symptoms be caused by a Vitamin B12 deficiency?

In this week's video, Dr. Brian Durie answers a question if the symptoms of Vitamin B12 deficiency is an effect of multiple myeloma treatment.

Bottom Line:

Look for other issues that could be causing symptoms that might be easily corrected.


Should you have a stem cell transplant even after a partial response to treatment?

In this week's video, Dr. Brian Durie discusses if a patient should have a stem cell transplant even after partial response to treatment.

The Bottom Line:

Even after partial remission stick with the plan.


How do I find a myeloma specialist in my area?

In this week's video, Dr. Brian Durie answers the question on how to find a specialist in an area and what steps to take if there are none.

Bottom Line:

Doctors, patients, and support groups will all help guide you to the best outcome.


What kinds of scan can determine if bone pain indicates new myeloma disease?

In this week's video, Dr. Brian Durie talks about the different imaging scans that can be used to determine if bone pain indicates new myeloma disease.

Bottom line:

It's very important for every patient to know via repeated scanning if new bone pain is significant.


How common is toxoplasmosis infection?

In this week's video, Dr. Brian Durie tackles the question on how common toxoplasmosis is and how multiple myeloma patients can protect themselves.

The Bottom Line: Patients need to work with their doctors to detect infections and make sure they are treated.


What are the practical details of FISH testing?

In this week's video, Dr. Brian Durie discusses the practical details of Flourescent In Situ Hybridization (FISH) testing.


Whats the latest update on the Black Swan Research Initiative®?

In this week's video, Dr. Brian Durie gives an update on the exciting developments happening on the Black Swan Research Initiative®.

 


Is the combination of Kyprolis, Cytoxan and dexamethasone available as a treatment?

In this week's video, Dr. Brian Durie answers a patient's question if the combination of Kyprolis, Cytoxan, and dexamethasone is available as a treatment.


Are veterans with myeloma a unique population?

In this week's video, Dr. Brian Durie answers the question "Are veterans with myeloma a unique population?" Dr. Durie also talked about the challenges that veterans face to get the best care available to them. For more information about veterans with myeloma you can visit: www.veterans.myeloma.org .


How does myeloma affect the immune system?

In this week's video, Dr. Brian Durie discusses how does myeloma affect the immune system and what can be done for the iHommune system to work better.


What is IVIG?

In this week's #AskDrDurie video, IMF Chairman Dr. Brian Durie discusses how Intravenous Immunogloblin is being used as a treatment option for multiple myeloma.


Is chiropractic care an option for patients with myeloma?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the risks that can come with chiropractic care for patients with myeloma. He also offers some alternative therapeutic options for those who need them.


Does pomalidomide work on a myeloma patient that has not had a response with other iMiDs?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the success a myeloma patient can have with pomalidomide, even if that patient has not had a response with other drugs in the iMiD category.


When will the first monoclonal antibody be approved?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the progress being made with monoclonal antibodies being used to treat myeloma. He highlights three specific ones (daratumumab, Sanofi’s SAR compound, and elotuzumab) and discusses why each is promising.


If stringent complete remission is achieved, is maintenance therapy still required?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie offers his take on whether or not maintenance is recommended for a patient who has already achieved a stringent complete remission (SCR) with his or her myeloma.


What are myeloma treatment options for a patient with bipolar disorder?

In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.


Does the type of myeloma impact the choice of treatment?

In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.


Dr. Durie, what is your perspective on the discussion about the cost of cancer drugs?

IMF Chairman Dr. Brian Durie weighed in on the high cost of cancer drugs after the recent article in Mayo Clinic Proceedings. He discusses what needs to be done within the healthcare system to better serve the patients.


What is the recommended use of Biaxin in patients with myeloma?

In this episode of the IMF's weekly web series, #AskDrDurie, IMF Chairman Dr. Brian Durie discusses his recommendation for use of the antibiotic Biaxin for patients with myeloma.


What is the typical speed of improvement in the Freelite and protein levels with myeloma treatment?

In this new episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses how fast a myeloma patient would see improvement in both Freelite and protein levels with treatment such as three-drug combinations.


What are some treatment options for the t(4;14) abnormality?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses treatment options available for those myeloma patients with the t(4;14) abnormality, including IMiDs, next-generation proteasome inhibitors, novel combination therapies, and autologous stem cell transplants.


What does ‘dysplasia’ mean within the bone marrow report?

In this episode of the IMF’s weekly web series, #AskDrDurie, IMF Chairman Dr. Brian Durie explains what dysplasia means when it shows up on a bone marrow report.


Should gadolinium be used as part of MRI testing?

In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie discusses the use of gadolinium in MRI testing, specifically for patients with abnormal kidney function.


What is the M protein?

This week, Dr. Brian Durie of the IMF answers a patient's question about the M protein and how levels are affected by time and treatment.


If bone density is low, does that mean myeloma is present?

In this week's episode of #AskDrDurie, IMF Chairman Dr. Brian Durie answers a patient's question about levels of bone density and how they connect to myeloma.


What is the 17p deletion?

In this week’s episode of #AskDrDurie Dr. Brian Durie discusses the importance of the 17p deletion chromosome abnormality when remission has been achieved.


#AskDrDurie: What’s new with the Black Swan Research Initiative®?

In the first episode of the new year, Dr. Brian Durie of the IMF looks back on the progress of a signature project, the Black Swan Research Initiative® to discuss major accomplishments in 2014.


#AskDrDurie: What does IMWG’s new diagnostic criteria mean for myeloma patients?

In this episode of #AskDrDurie, Dr. Brian Durie talks about the new diagnostic guidelines and tests that can be used to diagnose myeloma early, before CRAB features have emerged. These criteria have been published in a new publication available on myeloma.org.


#AskDrDurie: Why wasn’t panobinostat approved?

In this episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a  patient's question about why the recent FDA ODAC hearing rejected the use of new drug panobinostat for myeloma. He also discusses other HDAC inhibitors that are currently in development.


#AskDrDurie: What's new at ASH 2014

In this week’s special #AskDrDurie episode, Dr. Brian Durie of the IMF takes a look at the December 2014 ASH (American Society of Hematology) meeting in San Francisco. He previews what abstracts will be presented and talks about news to expect out of the meeting.


#AskDrDurie: Can Cytoxan cause heart damage?

In this week's #AskDrDurie, the IMF's Dr. Brian G.M. Durie answers a patient's concern regarding myeloma treatment and heart damage--specifically when it comes to the drug Cytoxan.


#AskDrDurie: What happens to stem cells once they are harvested?

In this week's episode of #AskDrDurie, Dr. Brian G.M. Durie of the IMF answers a patient's question regarding stem cells. If they are harvested in a specific facility, can they be moved and stored elsewhere later?
 
Find out the answer in this video!


#AskDrDurie: Can the Hevylite™ test be used to monitor IgA myeloma?

In this week’s episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a patient question regarding IgA myeloma and tests used to monitor it, specifically the Hevylite™ test. Watch this video to learn all about Hevylite.


#AskDrDurie: Is it possible to have short remissions without high-risk features?

Inspired by last week's #AskDrDurie episode in which Dr. Brian Durie of the IMF explained the definition of remission when it comes to  myeloma patients, this new episodes is a follow-up. Here, Dr. Durie explains why a myeloma patient might experience a short remission period, even if high-risk features have not been identified.


#AskDrDurie: What is remission?

In the latest episode of #AskDrDurie, Dr. Brian Durie of the IMF explains what remission means for myeloma patients.


#AskDrDurie: How does the IMF contribute to the myeloma community?

In the latest episode of #AskDrDurie, Dr. Brian Durie addresses a patient who has just learned about the IMF by explaining three key contributions the IMF makes to myeloma research and education.


#AskDrDurie: What is Selinexor

In this week's episode of #AskDrDurie, Dr. Brian Durie of the IMF takes a question from a patient who has relapsing myeloma and is wondering about the new drug Selinexor. Dr. Durie explains what the drug is and how it can be used in myeloma.


#AskDrDurie: Is autologous stem cell transplant still recommended?

In this episode of the IMF’s #AskDrDurie web series, Dr. Brian Durie talks about when and for what kind of myeloma patient an autologous stem cell transplant (ASCT) is recommended.


#AskDrDurie: Has there been any change in recommendations used to treat bone disease in myeloma?

In this week's episode of #AskDrDurie, the IMF's Chairman Dr. Brian Durie answers a patient's question regarding how bone disease in myeloma is treated. He discusses bisphosphonates such as Aredia and Zometa and what the current recommendations are.


#AskDrDurie: If Pomalyst does not produce a full response, what are my options?

In this episode of #AskDrDurie, Dr. Brian Durie explores options for myeloma treatment if a patient isn’t receiving a full response from Pomalyst.


#AskDrDurie: Is there a test available for measuring Minimal Residual Disease, what we call MRD?

In this week's #AskDrDurie, the IMF's Dr. Brian Durie answers a very important question regarding the tests available for measuring Minimal Residual Disease. As you may know, the IMF's Black Swan Research Initiative(R) has been evaluating a new flow test method for this, and it is becoming a new benchmark.


#AskDrDurie: How can Revlimid’s diarrhea side effect be handled?

In this episode of #AskDrDurie, the IMF's Dr. Brian Durie answers a patient's question about dealing with a specific side effect from Revlimid.


#AskDrDurie: Is it okay to take vitamin B12 on the same day as Velcade?

In this episode of #AskDrDurie, Dr. Brian Durie of the IMF answers a myeloma patient’s question about taking a supplement like vitamin B12 on the same day as Velcade.


#AskDrDurie: What are the important aspects of different types of imaging, such as regular x-rays, MRI, CT, and PET?
In this week's #AskDrDurie episode, Dr. Brian Durie of the IMF explains the difference between x-rays, MRI, CT, and PET image scans. Each one has its place in detecting myeloma, and he walks viewers through each.

#AskDrDurie: Should I have an ASCT if I've been through therapy and am in remission?

In this week's #AskDrDurie, IMF Chairman and Co-Founder, Dr. Brian Durie answers a patient's inquiry about the benefits and necessity of having an autologous stem cell transplant (ASCT) if treatment for myeloma has already been completed, with remission as the result.


#AskDrDurie: How can myeloma suddenly go from standard to high risk?
In this episode of #AskDrDurie, IMF Co-Founder and Chairman Dr. Brian G.M. Durie answers a patient submitted question regarding receiving an initial diagnosis of standard myeloma, having treatment, and then being told the myeloma was high risk. He explains when and why that can happen and discusses different kinds of testing involved.

#AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie talks about what a low white blood cell count means when it comes to myeloma.


#AskDrDurie: Does age make a difference in selecting myeloma treatment?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie discusses the important factors one must consider when selecting individualized treatment for myeloma.


#AskDrDurie: Is MRI testing important to see if treatment is necessary for smoldering myeloma?

In this episode of #AskDrDurie, Dr. Brian Durie discusses the importance of MRI testing, specifically when it comes to patients with smoldering myeloma.


#AskDrDurie: Are there maintenance therapy recommendations for myeloma patients with t(4;14)?

In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie addresses a question about what kind of maintenance therapy is recommended for those myeloma patients who have the t(4;14) chromosome abnormality.


#AskDrDurie: Are clinical trials part of the Black Swan Research Initiative(R), and if so, how can I participate?

In this episode of #AskDrDurie, Dr. Brian Durie, IMF Chairman and Co-Founder, talks about the Black Swan Research Initiative(R)'s various clinical trials and how eligible patients can get more information and potentially participate in them.


#AskDrDurie: How does the new flow cytometry testing for MRD compare to molecular testing?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman and Co-Founder, discusses the sensitivity and accessibility of the flow cytometry method of MRD testing. 


#AskDrDurie: Are PET/CT scans useful for a patient with MGUS?

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, explains what MGUS means and why PET/CT scans are the most effective way to exclude unsuspected lesions that may occur in patients.


#AskDrDurie: In light of Tom Brokaw's recent myeloma diagnosis, is better early screening required?"

In this episode of #AskDrDurie, Dr. Brian G.M. Durie, IMF Chairman, discusses the importance of early detection screenings in order to diagnose myeloma. Find out why there is a constant need for awareness and monitoring of any changes in test results.


#AskDrDurie: Should Patients With Similar Types of Myeloma Form Separate Support Groups?

#AskDrDurie: If Myeloma Is Diagnosed, Is It Okay to Start With A Holistic Type of Approach First?

#AskDrDurie: My Maintenance was Stopped Because the Side Effects were Too Bad. How Common is That?

#AskDrDurie: My Doctor Thinks the Myeloma Treatment is Damaging my Liver: Is That Correct?

#AskDrDurie: Is Stopping Pomalidomide After 1 Month Okay?

#AskDrDurie: Does "Big Data Analysis" Apply to Myeloma Patients?

#AskDrDurie: If Myeloma is CD 38 Positive, Shouldn't Anti-CD 38 Antibodies Work for All Patients?

#AskDrDurie: I Need to Have Surgery: Can I Do That?

#AskDrDurie: Is Partial Response Or Very Good Partial Response Good Enough?

#AskDrDurie: Can Myeloma Run In The Family?

#AskDrDurie: What About The Role Of Antibody Therapy In Myeloma?

#AskDrDurie: What Is "Off Label" Use?

#AskDrDurie: What Is Recommended for Smoldering Myeloma?

#AskDrDurie: Should I be in a Clinical Trial

#AskDrDurie: How Can Myeloma Patients Avoid Infection?

#AskDrDurie: Are There Special Precautions for Myeloma Patients in the Summer?

#AskDrDurie: Should I Be On Maintenance Therapy?

#AskDr.Durie: Is Chemobrain Real?

#AskDrDurie: What Diet Is Recommended For Myeloma Patients?

#AskDrDurie: What's New From ASCO/EHA/IMWG Summit?

#AskDrDurie: Is MGUS A Tumor, And What Is Being Done To Prevent It?

#AskDrDurie: ASCT For Younger Patients - Is Disease "Control" Sufficient?

#AskDrDurie: Can Zometa® be used alone to treat myeloma with bone disease?

#AskDrDurie: Are Cataracts a Side Effect of Treatment with Revlimid?

#AskDrDurie: How Do I Get Rid of Bone Pain?

#AskDrDurie: Is Kidney Transplant Possible for Myeloma Patients?

#AskDrDurie: Which of the new treatments are the most exciting?

#AskDrDurie: How close are we to a cure?